Globular adiponectin ameliorates metabolic insulin resistance via AMPK‐mediated restoration of microvascular insulin responses
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Key points: Adiponectin is an adipokine with anti‐inflammatory and anti‐diabetic properties. Hypoadiponectinaemia is closely associated with endothelial dysfunction and insulin resistance in obesity and diabetes. Insulin resistance is present in muscle microvasculature and this may contribute to decreased insulin delivery to, and action in, muscle. In this study we examined whether adiponectin ameliorates metabolic insulin resistance by affecting muscle microvascular recruitment. We demonstrated that a high‐fat diet induces vascular adiponectin and insulin resistance but globular adiponectin administration can restore vascular insulin responses and improve insulin's metabolic action via an AMPK‐ and nitric oxide‐dependent mechanism. This suggests that globular adiponectin might have a therapeutic potential for improving insulin resistance and preventing cardiovascular complications in patients with diabetes via modulation of microvascular insulin responses. Hypoadiponectinaemia is closely associated with endothelial dysfunction and insulin resistance, and microvasculature plays a critical role in the regulation of insulin action in muscle. Here we tested whether adiponectin replenishment could improve metabolic insulin sensitivity in male rats fed a high‐fat diet (HFD) via the modulation of microvascular insulin responses. Male Sprague–Dawley rats were fed either a HFD or low‐fat diet (LFD) for 4 weeks. Small resistance artery myograph changes in tension, muscle microvascular recruitment and metabolic response to insulin were determined. Compared with rats fed a LFD, HFD feeding abolished the vasodilatory actions of globular adiponectin (gAd) and insulin on pre‐constricted distal saphenous arteries. Pretreatment with gAd improved insulin responses in arterioles isolated from HFD rats, which was blocked by AMP‐activated protein kinase (AMPK) inhibition. Similarly, HFD abolished microvascular responses to either gAd or insulin and decreased insulin‐stimulated glucose disposal by ∼60%. However, supplementing gAd fully rescued insulin's microvascular action and significantly improved the metabolic responses to insulin in HFD male rats and these actions were abolished by inhibition of either AMPK or nitric oxide production. We conclude that HFD induces vascular adiponectin and insulin resistance but gAd administration can restore vascular insulin responses and improve insulin's metabolic action via an AMPK‐ and nitric oxide‐dependent mechanism in male rats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Jongh, R. T., Serné, E. H., IJzerman, R. G., de Vries, G., & Stehouwer, C. D. A. (2004) · Circulation · doi:10.1161/01.cir.0000129772.26647.6f · Cited by 407 · cited 2×
“…from both clinical and animal studies suggests that microvascular dysfunction is present in obesity which may play a pathogenesis role in the development of metabolic insulin resistance in obesity and type 2 diabetes (Wallis et al. 2002; de Jongh et al. 2004; Clerk et al. 2006; Jonk et al. 2007).”
BackgroundAdiponectin Replenishment Ameliorates Obesity-Related Hypertension
Ohashi, K., Kihara, S., Ouchi, N., Kumada, M., Fujita, K., Hiuge, A., Hibuse, T., Ryo, M., Nishizawa, H., Maeda, N., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000222368.43759.a1 · Cited by 400
Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke
McCullough, L. D., Zeng, Z., Li, H., Landree, L. E., McFadden, J., & Ronnett, G. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409985200 · Cited by 333
Barrett, E. J., Eggleston, E. M., Inyard, A. C., Wang, H., Li, G., Chai, W., & Liu, Z. (2009) · Diabetologia · doi:10.1007/s00125-009-1313-z · Cited by 323 · cited 1×
“Muscle microvasculature provides an endothelial surface area for substrate exchange between plasma and muscle interstitium and plays a pivotal role in the regulation of insulin delivery to, and action in, muscle (Clerk et al. 2004; Barrett et al. 2009).”
BackgroundSelf-citationWang, C., Mao, X., Wang, L., Liu, M., Wetzel, M. D., Guan, K.-L., Dong, L. Q., & Liu, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700098200 · Cited by 210 · cited 1×
“This may reflect muscle adiponectin resistance as ample data have confirmed a direct action of gAd on muscle cells to increase GLUT4 translocation and glucose uptake and improve insulin actions in cultured muscle cells (Ceddia et al. 2005; Wang et al. 2007).”
BackgroundChai, W., Dong, Z., Wang, N., Wang, W., Tao, L., Cao, W., & Liu, Z. (2012) · Diabetes · doi:10.2337/db11-1073 · Cited by 194 · cited 2×
“…that increase muscle microvascular perfusion, such as exercise, insulin, glucagon-like peptide1, ranolazine and angiotensin II type 1 receptor blockade are all capable of increasing muscle insulin delivery and action (Vincent et al. 2004; Inyard et al. 2007; Chai et al. 2011, 2012; Fu et al. 2013).”
BackgroundSelf-citationInsulin-Mediated Hemodynamic Changes Are Impaired in Muscle of Zucker Obese Rats
Wallis, M. G., Wheatley, C. M., Rattigan, S., Barrett, E. J., Clark, A. D. H., & Clark, M. G. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3492 · Cited by 164 · cited 2×
“Mounting evidence from both clinical and animal studies suggests that microvascular dysfunction is present in obesity which may play a pathogenesis role in the development of metabolic insulin resistance in obesity and type 2 diabetes (Wallis et al. 2002; de Jongh et al. 2004; Clerk et al. 2006; Jonk et al. 2007).”
BackgroundSelf-citationPALANIVEL, R., FANG, X., PARK, M., EGUCHI, M., PALLAN, S., DEGIROLAMO, S., LIU, Y., WANG, Y., XU, A., & SWEENEY, G. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.011 · Cited by 117 · cited 1×
“Indeed, replenishment of adiponectin via either injection or adenovirus-mediated overexpression improves insulin sensitivity in rats (Fruebis et al. 2001; Yamauchi et al. 2001, 2002, 2003; Satoh et al. 2005; Palanivel et al. 2007).”
BackgroundWang, N., Ko, S.-H., Chai, W., Li, G., Barrett, E. J., Tao, L., Cao, W., & Liu, Z. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00414.2010 · Cited by 28 · cited 1×
“In the presence of insulin resistance, as seen in obesity or during systemic lipid or tumour necrosis factor α infusion, microvascular insulin responses are blunted (Clerk et al. 2006; Wang et al. 2011, 2013).”
BackgroundSelf-citation
Cited by
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
Achari, A., & Jain, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061321 · Cited by 1,158
Adiponectin regulation and function
Fang, H., & Judd, R. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170046 · Cited by 631
Adiponectin signaling and function in insulin target tissues
Ruan, H., & Dong, L. Q. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw014 · Cited by 395
Chai, W., Fu, Z., Aylor, K. W., Barrett, E. J., & Liu, Z. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00205.2016 · Cited by 51
Self-citationLiu, J., Aylor, K. W., & Liu, Z. (2023) · Diabetes · doi:10.2337/db22-0745 · Cited by 30
Self-citation
Metadata
- Authors
- Zhao, L., Fu, Z., Wu, J., Aylor, K. W., Barrett, E. J., Cao, W., & Liu, Z.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2015-07-26
- Volume
- 593
- Issue
- 17
- Pages
- 4067-4079
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W2149893269
- Cited by
- 50
- References
- 9
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.